APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biosimilar Development Services

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Biosimilar Development Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 May 2026191 pages

Choose your research edition.

Industry ResearchBiosimilar Development Services Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Biosimilar Development Services Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Biosimilar Development Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biosimilar Development Services Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Biosimilar Development Services Market Analysis and Forecast 2026-2032183 pages · $4,950 USD

Market perspective

The global Biosimilar Development Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Biosimilar Development Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biosimilar Development Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biosimilar Development Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Biosimilar Development Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biosimilar Development Services include 3P Bio, BioPharmaSpec, Charles River Laboratories, ICON, Intertek, JSR Life Sciences, Labcorp, Syneos Health and PPD Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Biosimilar Development Services market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biosimilar Development Services and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biosimilar Development Services revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Biosimilar Development Services market size, projected growth trends, production technologies, key applications, and end-use industries.

Biosimilar Development Services Segment by Company

3P Bio

BioPharmaSpec

Charles River Laboratories

ICON

Intertek

JSR Life Sciences

Labcorp

Syneos Health

PPD Inc

Profacgen

Sartorius

SGS S.A.

Biosimilar Development Services Segment by Type

Insulin

Anti-Cancer Drugs

Others

Biosimilar Development Services Segment by Application

Cancer

Diabetes

Arthritis

Psoriasis

Neutropenia

Enzyme or Hormone Deficiency

Others

Biosimilar Development Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biosimilar Development Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biosimilar Development Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biosimilar Development Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Biosimilar Development Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biosimilar Development Services industry.

Chapter 3: Detailed analysis of Biosimilar Development Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biosimilar Development Servicesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biosimilar Development Services Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Insulin Table 3. Key Players of Anti-Cancer Drugs Table 4. Key Players of Others Table 4. Global Biosimilar Development Services Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Cancer Table 6. Key Players of Diabetes Table 7. Key Players of Arthritis Table 8. Key Players of Psoriasis Table 9. Key Players of Neutropenia Table 10. Key Players of Enzyme or Hormone Deficiency Table 11. Key Players of Others Table 12. Global Biosimilar Development Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Biosimilar Development Services Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Biosimilar Development Services Market Share by Region (2021-2026) Table 15. Global Biosimilar Development Services Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Biosimilar Development Services Market Share by Region (2027-2032) Table 17. Biosimilar Development Services Industry Trends Table 18. Biosimilar Development Services Industry Drivers Table 19. Biosimilar Development Services Industry Opportunities and Challenges Table 20. Biosimilar Development Services Industry Restraints Table 21. Global Biosimilar Development Services Revenue by Company (US$ Million) & (2021-2026) Table 22. Global Biosimilar Development Services Revenue Market Share by Company (2021-2026) Table 23. Global Biosimilar Development Services Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 24. Global Biosimilar Development Services Key Company Head Office and Area Served Table 25. Global Biosimilar Development Services Company, Product Type & Application Table 26. Global Biosimilar Development Services Company Establishment Date Table 27. Global Company Market Concentration Ratio (CR5 and HHI) Table 28. Global Biosimilar Development Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 29. Global Biosimilar Development Services Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Biosimilar Development Services Market Size by Type (2021-2026) & (US$ Million) Table 31. Global Biosimilar Development Services Market Size by Type (2027-2032) & (US$ Million) Table 32. Global Biosimilar Development Services Revenue Market Share by Type (2021-2026) Table 33. Global Biosimilar Development Services Revenue Market Share by Type (2027-2032) Table 34. Global Biosimilar Development Services Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Biosimilar Development Services Market Size by Application (2021-2026) & (US$ Million) Table 36. Global Biosimilar Development Services Market Size by Application (2027-2032) & (US$ Million) Table 37. Global Biosimilar Development Services Revenue Market Share by Application (2021-2026) Table 38. Global Biosimilar Development Services Revenue Market Share by Application (2027-2032) Table 39. 3P Bio Company Information Table 40. 3P Bio Business Overview Table 41. 3P Bio Biosimilar Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. 3P Bio Biosimilar Development Services Product Portfolio Table 43. 3P Bio Recent Development Table 44. BioPharmaSpec Company Information Table 45. BioPharmaSpec Business Overview Table 46. BioPharmaSpec Biosimilar Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. BioPharmaSpec Biosimilar Development Services Product Portfolio Table 48. BioPharmaSpec Recent Development Table 49. Charles River Laboratories Company Information Table 50. Charles River Laboratories Business Overview Table 51. Charles River Laboratories Biosimilar Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Charles River Laboratories Biosimilar Development Services Product Portfolio Table 53. Charles River Laboratories Recent Development Table 54. ICON Company Information Table 55. ICON Business Overview Table 56. ICON Biosimilar Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. ICON Biosimilar Development Services Product Portfolio Table 58. ICON Recent Development Table 59. Intertek Company Information Table 60. Intertek Business Overview Table 61. Intertek Biosimilar Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Intertek Biosimilar Development Services Product Portfolio Table 63. Intertek Recent Development Table 64. JSR Life Sciences Company Information Table 65. JSR Life Sciences Business Overview Table 66. JSR Life Sciences Biosimilar Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. JSR Life Sciences Biosimilar Development Services Product Portfolio Table 68. JSR Life Sciences Recent Development Table 69. Labcorp Company Information Table 70. Labcorp Business Overview Table 71. Labcorp Biosimilar Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Labcorp Biosimilar Development Services Product Portfolio Table 73. Labcorp Recent Development Table 74. Syneos Health Company Information Table 75. Syneos Health Business Overview Table 76. Syneos Health Biosimilar Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Syneos Health Biosimilar Development Services Product Portfolio Table 78. Syneos Health Recent Development Table 79. PPD Inc Company Information Table 80. PPD Inc Business Overview Table 81. PPD Inc Biosimilar Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. PPD Inc Biosimilar Development Services Product Portfolio Table 83. PPD Inc Recent Development Table 84. Profacgen Company Information Table 85. Profacgen Business Overview Table 86. Profacgen Biosimilar Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Profacgen Biosimilar Development Services Product Portfolio Table 88. Profacgen Recent Development Table 89. Sartorius Company Information Table 90. Sartorius Business Overview Table 91. Sartorius Biosimilar Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Sartorius Biosimilar Development Services Product Portfolio Table 93. Sartorius Recent Development Table 94. SGS S.A. Company Information Table 95. SGS S.A. Business Overview Table 96. SGS S.A. Biosimilar Development Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. SGS S.A. Biosimilar Development Services Product Portfolio Table 98. SGS S.A. Recent Development Table 99. North America Biosimilar Development Services Market Size by Type (2021-2026) & (US$ Million) Table 100. North America Biosimilar Development Services Market Size by Type (2027-2032) & (US$ Million) Table 101. North America Biosimilar Development Services Market Size by Application (2021-2026) & (US$ Million) Table 102. North America Biosimilar Development Services Market Size by Application (2027-2032) & (US$ Million) Table 103. North America Biosimilar Development Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. North America Biosimilar Development Services Market Size by Country (2021-2026) Table 105. North America Biosimilar Development Services Market Size by Country (2027-2032) Table 106. Europe Biosimilar Development Services Market Size by Type (2021-2026) & (US$ Million) Table 107. Europe Biosimilar Development Services Market Size by Type (2027-2032) & (US$ Million) Table 108. Europe Biosimilar Development Services Market Size by Application (2021-2026) & (US$ Million) Table 109. Europe Biosimilar Development Services Market Size by Application (2027-2032) & (US$ Million) Table 110. Europe Biosimilar Development Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Europe Biosimilar Development Services Market Size by Country (2021-2026) Table 112. Europe Biosimilar Development Services Market Size by Country (2027-2032) Table 113. China Biosimilar Development Services Market Size by Type (2021-2026) & (US$ Million) Table 114. China Biosimilar Development Services Market Size by Type (2027-2032) & (US$ Million) Table 115. China Biosimilar Development Services Market Size by Application (2021-2026) & (US$ Million) Table 116. China Biosimilar Development Services Market Size by Application (2027-2032) & (US$ Million) Table 117. Asia Biosimilar Development Services Market Size by Type (2021-2026) & (US$ Million) Table 118. Asia Biosimilar Development Services Market Size by Type (2027-2032) & (US$ Million) Table 119. Asia Biosimilar Development Services Market Size by Application (2021-2026) & (US$ Million) Table 120. Asia Biosimilar Development Services Market Size by Application (2027-2032) & (US$ Million) Table 121. Asia Biosimilar Development Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Asia Biosimilar Development Services Market Size by Country (2021-2026) Table 123. Asia Biosimilar Development Services Market Size by Country (2027-2032) Table 124. South America, Middle East & Africa Biosimilar Development Services Market Size by Type (2021-2026) & (US$ Million) Table 125. South America, Middle East & Africa Biosimilar Development Services Market Size by Type (2027-2032) & (US$ Million) Table 126. South America, Middle East & Africa Biosimilar Development Services Market Size by Application (2021-2026) & (US$ Million) Table 127. South America, Middle East & Africa Biosimilar Development Services Market Size by Application (2027-2032) & (US$ Million) Table 128. South America, Middle East & Africa Biosimilar Development Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. South America, Middle East & Africa Biosimilar Development Services Market Size by Country (2021-2026) Table 130. South America, Middle East & Africa Biosimilar Development Services Market Size by Country (2027-2032) Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Biosimilar Development Services Product Image Figure 2. Global Biosimilar Development Services Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Biosimilar Development Services Market Share by Type: 2025 VS 2032 Figure 4. Insulin Image Figure 5. Anti-Cancer Drugs Image Figure 6. Others Image Figure 7. Global Biosimilar Development Services Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Biosimilar Development Services Market Share by Application: 2025 VS 2032 Figure 9. Cancer Image Figure 10. Diabetes Image Figure 11. Arthritis Image Figure 12. Psoriasis Image Figure 13. Neutropenia Image Figure 14. Enzyme or Hormone Deficiency Image Figure 15. Others Image Figure 16. Global Biosimilar Development Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 18. Global Biosimilar Development Services Market Share by Region: 2025 VS 2032 Figure 19. Years Considered Figure 20. Global Biosimilar Development Services Market Share by Players in 2025 Figure 21. Global Top 5 and 10 Biosimilar Development Services Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Biosimilar Development Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Biosimilar Development Services Revenue Market Share by Type (2021-2032) Figure 25. Global Biosimilar Development Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Biosimilar Development Services Revenue Market Share by Application (2021-2032) Figure 27. North America Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 28. North America Biosimilar Development Services Market Share by Type (2021-2032) Figure 29. North America Biosimilar Development Services Market Share by Application (2021-2032) Figure 30. North America Biosimilar Development Services Market Share by Country (2021-2032) Figure 31. United States Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 32. Canada Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 33. Mexico Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 34. Europe Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 35. Europe Biosimilar Development Services Market Share by Type (2021-2032) Figure 36. Europe Biosimilar Development Services Market Share by Application (2021-2032) Figure 37. Europe Biosimilar Development Services Market Share by Country (2021-2032) Figure 38. Germany Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 39. France Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 40. U.K. Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 41. Italy Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 42. Russia Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 43. Nordic Countries Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 44. China Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 45. China Biosimilar Development Services Market Share by Type (2021-2032) Figure 46. China Biosimilar Development Services Market Share by Application (2021-2032) Figure 47. Asia Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 48. Asia Biosimilar Development Services Market Share by Type (2021-2032) Figure 49. Asia Biosimilar Development Services Market Share by Application (2021-2032) Figure 50. Asia Biosimilar Development Services Market Share by Country (2021-2032) Figure 51. Japan Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 52. South Korea Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 53. Taiwan Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 54. Southeast Asia Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 55. India Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 56. Australia Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Biosimilar Development Services Market Share by Type (2021-2032) Figure 59. South America, Middle East & Africa Biosimilar Development Services Market Share by Application (2021-2032) Figure 60. South America, Middle East & Africa Biosimilar Development Services Market Share by Country (2021-2032) Figure 61. Brazil Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 62. South Africa Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 63. Saudi Arabia Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 64. Turkey Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 65. Argentina Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 66. UAE Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 67. Egypt Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 68. Chile Biosimilar Development Services Market Size (2021-2032) & (US$ Million) Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Insulin
  • Anti-Cancer Drugs
  • Others
Applications
  • Cancer
  • Diabetes
  • Arthritis
  • Psoriasis
  • Neutropenia
  • Enzyme or Hormone Deficiency
  • Others
Companies covered
  • 3P Bio
  • BioPharmaSpec
  • Charles River Laboratories
  • ICON
  • Intertek
  • JSR Life Sciences
  • Labcorp
  • Syneos Health
  • PPD Inc
  • Profacgen
  • Sartorius
  • SGS S.A.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Biosimilar Development Services Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Insulin
  5. 1.2.3 Anti-Cancer Drugs
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Biosimilar Development Services Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Cancer
  10. 1.3.3 Diabetes
  11. 1.3.4 Arthritis
  12. 1.3.5 Psoriasis
  13. 1.3.6 Neutropenia
  14. 1.3.7 Enzyme or Hormone Deficiency
  15. 1.3.8 Others
  16. 1.4 Global Market Growth Prospects
  17. 1.5 Global Biosimilar Development Services Growth Trends by Region
  18. 1.5.1 Global Biosimilar Development Services Market Size by Region: 2021 VS 2025 VS 2032
  19. 1.5.2 Biosimilar Development Services Market Size by Region (2021-2026)
  20. 1.5.3 Biosimilar Development Services Market Size by Region (2027-2032)
  21. 1.6 Assumptions and Limitations
  22. 1.7 Study Goals and Objectives
  23. 1.8 Years Considered
2 Global Biosimilar Development Services Market Dynamics
  1. 2.1 Biosimilar Development Services Industry Trends
  2. 2.2 Biosimilar Development Services Industry Drivers
  3. 2.3 Biosimilar Development Services Industry Opportunities and Challenges
  4. 2.4 Biosimilar Development Services Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Biosimilar Development Services Revenue by Company (2021-2026)
  2. 3.2 Global Biosimilar Development Services Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Biosimilar Development Services Key Company Head office and Area Served
  4. 3.4 Global Biosimilar Development Services Company, Product Type & Application
  5. 3.5 Global Biosimilar Development Services Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Biosimilar Development Services Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Biosimilar Development Services Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Biosimilar Development Services Tier 1, Tier 2, and Tier 3
4 Biosimilar Development Services Market by Type
  1. 4.1 Global Biosimilar Development Services Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Biosimilar Development Services Market Size by Type (2021-2032)
  3. 4.3 Global Biosimilar Development Services Market Size Share by Type (2021-2032)
5 Biosimilar Development Services Market by Application
  1. 5.1 Global Biosimilar Development Services Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Biosimilar Development Services Market Size by Application (2021-2032)
  3. 5.3 Global Biosimilar Development Services Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 3P Bio
  2. 6.1.1 3P Bio Company Information
  3. 6.1.2 3P Bio Business Overview
  4. 6.1.3 3P Bio Biosimilar Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 3P Bio Biosimilar Development Services Product Portfolio
  6. 6.1.5 3P Bio Recent Developments
  7. 6.2 BioPharmaSpec
  8. 6.2.1 BioPharmaSpec Company Information
  9. 6.2.2 BioPharmaSpec Business Overview
  10. 6.2.3 BioPharmaSpec Biosimilar Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 BioPharmaSpec Biosimilar Development Services Product Portfolio
  12. 6.2.5 BioPharmaSpec Recent Developments
  13. 6.3 Charles River Laboratories
  14. 6.3.1 Charles River Laboratories Company Information
  15. 6.3.2 Charles River Laboratories Business Overview
  16. 6.3.3 Charles River Laboratories Biosimilar Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Charles River Laboratories Biosimilar Development Services Product Portfolio
  18. 6.3.5 Charles River Laboratories Recent Developments
  19. 6.4 ICON
  20. 6.4.1 ICON Company Information
  21. 6.4.2 ICON Business Overview
  22. 6.4.3 ICON Biosimilar Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 ICON Biosimilar Development Services Product Portfolio
  24. 6.4.5 ICON Recent Developments
  25. 6.5 Intertek
  26. 6.5.1 Intertek Company Information
  27. 6.5.2 Intertek Business Overview
  28. 6.5.3 Intertek Biosimilar Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Intertek Biosimilar Development Services Product Portfolio
  30. 6.5.5 Intertek Recent Developments
  31. 6.6 JSR Life Sciences
  32. 6.6.1 JSR Life Sciences Company Information
  33. 6.6.2 JSR Life Sciences Business Overview
  34. 6.6.3 JSR Life Sciences Biosimilar Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 JSR Life Sciences Biosimilar Development Services Product Portfolio
  36. 6.6.5 JSR Life Sciences Recent Developments
  37. 6.7 Labcorp
  38. 6.7.1 Labcorp Company Information
  39. 6.7.2 Labcorp Business Overview
  40. 6.7.3 Labcorp Biosimilar Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Labcorp Biosimilar Development Services Product Portfolio
  42. 6.7.5 Labcorp Recent Developments
  43. 6.8 Syneos Health
  44. 6.8.1 Syneos Health Company Information
  45. 6.8.2 Syneos Health Business Overview
  46. 6.8.3 Syneos Health Biosimilar Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Syneos Health Biosimilar Development Services Product Portfolio
  48. 6.8.5 Syneos Health Recent Developments
  49. 6.9 PPD Inc
  50. 6.9.1 PPD Inc Company Information
  51. 6.9.2 PPD Inc Business Overview
  52. 6.9.3 PPD Inc Biosimilar Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 PPD Inc Biosimilar Development Services Product Portfolio
  54. 6.9.5 PPD Inc Recent Developments
  55. 6.10 Profacgen
  56. 6.10.1 Profacgen Company Information
  57. 6.10.2 Profacgen Business Overview
  58. 6.10.3 Profacgen Biosimilar Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Profacgen Biosimilar Development Services Product Portfolio
  60. 6.10.5 Profacgen Recent Developments
  61. 6.11 Sartorius
  62. 6.11.1 Sartorius Company Information
  63. 6.11.2 Sartorius Business Overview
  64. 6.11.3 Sartorius Biosimilar Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Sartorius Biosimilar Development Services Product Portfolio
  66. 6.11.5 Sartorius Recent Developments
  67. 6.12 SGS S.A.
  68. 6.12.1 SGS S.A. Company Information
  69. 6.12.2 SGS S.A. Business Overview
  70. 6.12.3 SGS S.A. Biosimilar Development Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 SGS S.A. Biosimilar Development Services Product Portfolio
  72. 6.12.5 SGS S.A. Recent Developments
7 North America
  1. 7.1 North America Biosimilar Development Services Market Size (2021-2032)
  2. 7.2 North America Biosimilar Development Services Market Size by Type
  3. 7.2.1 North America Biosimilar Development Services Market Size by Type (2021-2026)
  4. 7.2.2 North America Biosimilar Development Services Market Size by Type (2027-2032)
  5. 7.2.3 North America Biosimilar Development Services Market Share by Type (2021-2032)
  6. 7.3 North America Biosimilar Development Services Market Size by Application
  7. 7.3.1 North America Biosimilar Development Services Market Size by Application (2021-2026)
  8. 7.3.2 North America Biosimilar Development Services Market Size by Application (2027-2032)
  9. 7.3.3 North America Biosimilar Development Services Market Share by Application (2021-2032)
  10. 7.4 North America Biosimilar Development Services Market Size by Country
  11. 7.4.1 North America Biosimilar Development Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Biosimilar Development Services Market Size by Country (2021-2026)
  13. 7.4.3 North America Biosimilar Development Services Market Size by Country (2027-2032)
  14. 7.4.4 North America Biosimilar Development Services Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Biosimilar Development Services Market Size (2021-2032)
  2. 8.2 Europe Biosimilar Development Services Market Size by Type
  3. 8.2.1 Europe Biosimilar Development Services Market Size by Type (2021-2026)
  4. 8.2.2 Europe Biosimilar Development Services Market Size by Type (2027-2032)
  5. 8.2.3 Europe Biosimilar Development Services Market Share by Type (2021-2032)
  6. 8.3 Europe Biosimilar Development Services Market Size by Application
  7. 8.3.1 Europe Biosimilar Development Services Market Size by Application (2021-2026)
  8. 8.3.2 Europe Biosimilar Development Services Market Size by Application (2027-2032)
  9. 8.3.3 Europe Biosimilar Development Services Market Share by Application (2021-2032)
  10. 8.4 Europe Biosimilar Development Services Market Size by Country
  11. 8.4.1 Europe Biosimilar Development Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Biosimilar Development Services Market Size by Country (2021-2026)
  13. 8.4.3 Europe Biosimilar Development Services Market Size by Country (2027-2032)
  14. 8.4.4 Europe Biosimilar Development Services Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Biosimilar Development Services Market Size (2021-2032)
  2. 9.2 China Biosimilar Development Services Market Size by Type
  3. 9.2.1 China Biosimilar Development Services Market Size by Type (2021-2026)
  4. 9.2.2 China Biosimilar Development Services Market Size by Type (2027-2032)
  5. 9.2.3 China Biosimilar Development Services Market Share by Type (2021-2032)
  6. 9.3 China Biosimilar Development Services Market Size by Application
  7. 9.3.1 China Biosimilar Development Services Market Size by Application (2021-2026)
  8. 9.3.2 China Biosimilar Development Services Market Size by Application (2027-2032)
  9. 9.3.3 China Biosimilar Development Services Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Biosimilar Development Services Market Size (2021-2032)
  2. 10.2 Asia Biosimilar Development Services Market Size by Type
  3. 10.2.1 Asia Biosimilar Development Services Market Size by Type (2021-2026)
  4. 10.2.2 Asia Biosimilar Development Services Market Size by Type (2027-2032)
  5. 10.2.3 Asia Biosimilar Development Services Market Share by Type (2021-2032)
  6. 10.3 Asia Biosimilar Development Services Market Size by Application
  7. 10.3.1 Asia Biosimilar Development Services Market Size by Application (2021-2026)
  8. 10.3.2 Asia Biosimilar Development Services Market Size by Application (2027-2032)
  9. 10.3.3 Asia Biosimilar Development Services Market Share by Application (2021-2032)
  10. 10.4 Asia Biosimilar Development Services Market Size by Country
  11. 10.4.1 Asia Biosimilar Development Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Biosimilar Development Services Market Size by Country (2021-2026)
  13. 10.4.3 Asia Biosimilar Development Services Market Size by Country (2027-2032)
  14. 10.4.4 Asia Biosimilar Development Services Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Biosimilar Development Services Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Biosimilar Development Services Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Biosimilar Development Services Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Biosimilar Development Services Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Biosimilar Development Services Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Biosimilar Development Services Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Biosimilar Development Services Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Biosimilar Development Services Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Biosimilar Development Services Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Biosimilar Development Services Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Biosimilar Development Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Biosimilar Development Services Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Biosimilar Development Services Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Biosimilar Development Services Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst